Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology
In: Antiviral Therapy Antiviral Therapy, International Medical Press, 2013, 18 (2), pp.193-204. ⟨10.3851/IMP2313⟩ Antiviral Therapy, 2013, 18 (2), pp.193-204. ⟨10.3851/IMP2313⟩; (2013)
Online
unknown
Zugriff:
Background Ubiquitous mitochondrial creatine kinase (uMtCK) accumulates as macroenzyme creatine kinase type 2 (macro CK2) in the serum of HIV-infected patients under a tenofovir disoproxil fumarate (TDF)-containing antiretroviral regimen. The genesis and clinical significance of this finding is unclear. Methods A prospective observational 5-year follow-up study was performed on those patients in which macro CK2 appearance was initially described (‘TDF switch study’ cohort). In addition, tenofovir (TFV), its prodrug TDF and its active, intracellular derivative TFV diphosphate (TDP) were tested in vitro for their effects on different key properties of uMtCK to clarify possible interactions of uMtCK with TFV compounds. Results In just under 5 years of continuous TDF treatment, only 4/12 (33%) patients remained macro CK2-positive, whereas 8/12 (66%) originally positive patients were macro CK2-negative at the end of follow-up. Prospective clinical follow-up data indicate that macro CK2 appearance under TDF is not associated with significant cell damage or occurrence of malignancies. A trend towards grade 1 hypophosphataemia suggests subclinical proximal tubular dysfunction in macro-CK2-positive patients, although it was not associated with a significant decrease in estimated glomerular filtration rate. In vitro, TFV, TDF and TDP did not interfere with uMtCK enzyme activity as competitive inhibitors or pseudo-substrates, but TFV and TDF stabilized the native uMtCK octameric structure in dilute solutions. Conclusions Appearance of octameric uMtCK as macro CK2 in the serum of TDF-treated patients is suggested to result from a combination of low-level mitochondrial damage caused by subclinical renal tubular dysfunction together with possible compensatory uMtCK overexpression and a putative concomitant stabilization of uMtCK octamers by higher levels of TFV in proximal tubules.
Titel: |
Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology
|
---|---|
Autor/in / Beteiligte Person: | Attia, Stéphane ; Goebel, Frank D. ; Lederer, Stephan R. ; Bogner, Johannes R. ; Füeßl, Birgit ; Schlattner, Uwe ; Kay, Laurence ; Schmid, Holger ; Tokarska-Schlattner, Malgorzata ; Röder, Maximilian ; Savoirs, Textes, Langage (STL) - UMR 8163 (STL) ; Université de Lille-Centre National de la Recherche Scientifique (CNRS) ; Laboratoire de bioénergétique fondamentale et appliquée (LBFA) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF) ; Poliklinik, Medizinische ; Ludwig-Maximilians-Universität München (LMU)-University of Munich Medical School ; Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM) |
Link: | |
Quelle: | Antiviral Therapy Antiviral Therapy, International Medical Press, 2013, 18 (2), pp.193-204. ⟨10.3851/IMP2313⟩ Antiviral Therapy, 2013, 18 (2), pp.193-204. ⟨10.3851/IMP2313⟩; (2013) |
Veröffentlichung: | HAL CCSD, 2013 |
Medientyp: | unknown |
ISSN: | 1359-6535 (print) |
Schlagwort: |
|
Sonstiges: |
|